论文部分内容阅读
目的:评价台湾男性膀胱恶性肿瘤患者接受膀胱前列腺根除手术后偶发性前列腺癌的发病率。方法:248位台湾男性膀胱移行性上皮癌患者接受膀胱前列腺根除手术后,进行前列腺病理切片分析。结果:在这248位患者中,10人(4.03%)的前列腺病理切片报告其患偶发性前列腺癌,其中8位处于 T1或 T2阶段、2位分别处于 T3和 T4阶段。本研究结果显示出的偶发性前列腺癌发病率低于美国同类研究所得出的发病率。结论:尽管偶发性前列腺癌在台湾膀胱恶性肿瘤患者中的发病率低于西方国家,但我们仍然建议在台湾男性膀胱癌患者,尤其是60岁以上患者的前列腺癌筛查过程中将肛门指检及前列腺特异抗原作为必要的常规检查项目,以避免偶发性前列腺癌的发生。
Objective: To evaluate the incidence of recurrent prostate cancer in patients with bladder cancer after radical prostatectomy in Taiwan. Methods: A total of 248 male bladder transitional epithelial cancer patients in Taiwan undergoing radical prostatectomy were analyzed for prostate pathology. RESULTS: Of 248 patients, prostate biopsies from 10 (4.03%) were reported to have incident prostate cancer, with 8 in stage T1 or T2 and 2 in stage T3 and T4, respectively. The results of this study show that the incidence of incidental prostate cancer is lower than the incidence of similar studies in the United States. CONCLUSIONS: Although the incidence of incidental prostate cancer in patients with bladder cancer in Taiwan is lower than in Western countries, we still recommend that anorectal examination be performed in prostate cancer screening in male bladder cancer patients in Taiwan, especially in patients over the age of 60 And prostate-specific antigen as a routine examination items necessary to avoid the occurrence of sporadic prostate cancer.